Reditest® Panel-Dip Card, 1 drug; Redwood #01-102-0019. Testing for BAR*.
Reditest® Panel-Dip, available in single and multi-drug urine test configurations: AMP, BAR, BUP, BZO, COC, EDDP, M-AMP, MDMA, MTD, OPI, OXY, PCP, PPX, TCA and THC*.
FDA 510(k) Cleared. Simple procedure: collect, dip and read results at 5 minutes.
Priced per case of 25 cards.
INTENDED USE STATEMENTS
- FOR PROFESSIONAL INVITRO DIAGNOSTIC USE ONLY.
DRUG SCREENS: Amphetamine (AMP1000 or AMP300), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Cocaine Metabolites (COC150 or COC300), Marijuana (THC), MDMA (Ecstasy), Methadone (MTD), Methamphetamine (M-AMP), Opiates (OPI300 or OPI2000), Oxycodone (OXY), Phencyclidine (PCP), Propoxyphene (PPX) and Tricyclic Antidepressants (TCA).
SPECIMEN VALIDITY TESTS: Creatinine (CR), Glutaraldehyde (GL), Nitrate (NI), Oxidants (OX), ph (PH), Specific Gravity (SG).
PRODUCT PROCEDURE NOTE:
Refer to product insert for complete instructions, limitations, and warnings.
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) or liquid chromatography/tandem mass spectrometry (LC/MS/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.